Lv5
1130 积分 2025-02-09 加入
Metabolic dysfunction-associated steatotic liver disease and the risk of mortality in individuals with type 2 diabetes: a systematic review and meta-analysis
16天前
已完结
Hepatic targeting of drugs and proteins by chemical modification
3个月前
已完结
Clinical study on relationship between Liver-Blood Stasis and Liver fibrosis
4个月前
已完结
Paeonol ameliorates hyperlipidemia and autophagy in mice by regulating Nrf2 and AMPK/mTOR pathways
4个月前
已完结
ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas
4个月前
已完结
Research progress of TCM intervention in MAFLD based on the AMPK-related signaling pathway
5个月前
已关闭
Expanding diagnostic and therapeutic horizons for MASH: Comparison of the latest and conventional therapeutic approaches
6个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
6个月前
已完结
The antihyperlipidemic effect of Fu-Ling-Pi is associated with abnormal fatty acid metabolism as assessed by UPLC-HDMS-based lipidomics
6个月前
已关闭
Metabolic dysfunction-associated steatohepatitis treatment: spotlight on the latest hepatoprotective drugs
8个月前
已完结
皖公网安备34019202002308
